Simultaneous Analysis of Fluoxetine, Norfluoxetine, Citalopram, and Haloperidol in Plasma by LC-ESI-IT-MS

被引:8
作者
El-Rjoob, Abdul-Wahab [1 ]
Tahtamouni, Munther [2 ]
Tahboub, Yahya R. [1 ,2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Appl Chem, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Princess Haya Ctr Biotechnol, Irbid 22110, Jordan
关键词
Column liquid chromatography-mass spectrometry; Fluoxetine; Norfluoxetine; Citalopram; Haloperidol; CHROMATOGRAPHY-MASS SPECTROMETRY; LIQUID-CHROMATOGRAPHY; FLUORESCENCE DETECTION; FORENSIC TOXICOLOGY; METABOLITES; DRUGS; BLOOD; MS/MS;
D O I
10.1365/s10337-010-1483-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reliable and simple method has been developed for simultaneous analysis of fluoxetine, its metabolite norfluoxetine, citalopram, and haloperidol with lamotrigine as internal standard. The method is based on solid-phase extraction on mixed-mode cation-exchange cartridges followed by LC separation on a C-18 column at ambient temperature with a gradient prepared from acetonitrile and 5 mM ammonium acetate in 0.1% (v/v) aqueous formic acid. The flow rate was 0.5 mL min(-1). Eluted compounds were ionized by the electrospray ionization ion source of an ion-trap mass spectrometer and were detected by selected ion monitoring. Co-extracted endogenous compounds from plasma were eluted in the first 5 min and discarded by valve-switching. The target drugs were eluted in the period 5.5-11 min. Calibration plots were linear in the ranges 5 (or 10)-400 ng mL(-1) with correlation coefficients > 0.999. Other statistical and validation results were within accepted ranges for clinical analysis.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 2001, Guidance for industry, bioanalytical method validation
[2]   The AGNP-TDM expert group consensus guidelines:: Therapeutic Drug Monitoring in psychiatry [J].
Baumann, P ;
Hiemke, C ;
Ulrich, S ;
Eckermann, G ;
Gaertner, I ;
Gerlach, M ;
Kuss, HJ ;
Laux, G ;
Müller-Oerlinghausen, B ;
Rao, ML ;
Riederer, P ;
Zernig, G .
PHARMACOPSYCHIATRY, 2004, 37 (06) :243-265
[3]  
COGTATAY N, 2001, BR J CLIN PHARM, V52, P103, DOI DOI 10.1111/J.1365-2125.2001.00088.X
[4]   Recent developments in analytical ion trap mass spectrometry [J].
Creaser, CS ;
Stygall, JW .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1998, 17 (10) :583-593
[5]   LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma -: Study of correlation between venlafaxine concentrations in both matrices [J].
de Castro, A. ;
Concheiro, M. ;
Quintela, O. ;
Cruz, A. ;
Lopez-Rivadulla, M. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (01) :183-193
[6]   EFFECT OF HALOPERIDOL AND ITS METABOLITES ON DOPAMINE AND NORADRENALINE UPTAKE IN RAT BRAIN-SLICES [J].
FANG, J ;
YU, PH .
PSYCHOPHARMACOLOGY, 1995, 121 (03) :379-384
[7]  
FURUKORI N, 2004, J CHROMATOGR B, V805, P175, DOI DOI 10.1016/J.JCHROMB.2004.02.043
[8]   Multidimensional on-line SPE for undisturbed LC-MS-MS analysis of basic drugs in biofluids [J].
Georgi, K. ;
Boos, K. -S. .
CHROMATOGRAPHIA, 2006, 63 (11-12) :523-531
[9]  
Gross AS, 2001, BRIT J CLIN PHARMACO, V52, p5S
[10]   Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis [J].
Hall, WD ;
Mant, A ;
Mitchell, PB ;
Rendle, VA ;
Hickie, IB ;
McManus, P .
BRITISH MEDICAL JOURNAL, 2003, 326 (7397) :1008-1011